HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Nakamura, T. Articles by Wong, N. C. W. Search for Related Content PubMed PubMed Citation Articles by Nakamura, T. Articles by Wong, N. C. W. Social Bookmarking                      What's this?

Journal of Lipid Research, Vol. 40, 1709-1718, September 1999
Copyright © 1999 by Lipid Research, Inc.

Original Article

Transcription factors and age-related decline in apolipoprotein A-I expression

Correspondence to: Norman C. W. Wong

Apolipoprotein (apo)A-I alone or as a component of high density lipoprotein particles has antiatherogenic properties. The age-dependent decline in abundance of this protein may underlie the higher risk for developing occlusive coronary artery disease (CAD) in older individuals. Similar to humans, expression of rat apoA-I also declines with age. Results in rats showed that levels of serum apoA-I protein, hepatic mRNA, and transcription of the gene were decreased to 39%, 18%, and 38%, respectively, in 180-day-old animals compared to those of newborn rats. These findings suggest that a nuclear mechanism(s) may account for the decline in apoA-I expression. Accordingly, we examined hepatic nuclear binding activity to four specific cis-acting elements of the rat apoA-I promoter. There were age-dependent changes of binding activity to two proximal sites, B and C, but not to the more distal elements, IRCE and A. Decreased B-site binding activity correlated with lower mRNA levels encoding the activator, HNF-3ß. The age-dependent change in the pattern of binding to site C was due to a switch from the activator, HNF-4, to the repressor, ARP-1.

In summary, the age-related decline in apoA-I expression may arise from a reduction in the activity of both cis-acting elements, B and C.—Nakamura, T., A. Fox-Robichaud, R. Kikkawa, A. Kashiwagi, H. Kojima, M. Fujimiya, and N. C. W. Wong. Transcription factors and age-related decline in apolipoprotein A-I expression. J. Lipid Res. 1999. 40: 1709;–1718.

Supplementary key words: aging, atherosclerosis, HNF-3, HNF-4, ARP-1, lipoprotein, cholesterol, HDL

CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				T. Kudo, M. Kawashima, T. Tamagawa, and S. Shibata Clock mutation facilitates accumulation of cholesterol in the liver of mice fed a cholesterol and/or cholic acid diet Am J Physiol Endocrinol Metab, January 1, 2008; 294(1): E120 - E130. [Abstract] [Full Text] [PDF]

				S. A. Myers, S.-C. M. Wang, and G. E. O. Muscat The Chicken Ovalbumin Upstream Promoter-Transcription Factors Modulate Genes and Pathways Involved in Skeletal Muscle Cell Metabolism J. Biol. Chem., August 25, 2006; 281(34): 24149 - 24160. [Abstract] [Full Text] [PDF]

				R. Rodriguez-Calvo, M. Jove, T. Coll, A. Camins, R. M. Sanchez, M. Alegret, M. Merlos, M. Pallas, J. C. Laguna, and M. Vazquez-Carrera PGC-1{beta} Down-Regulation Is Associated With Reduced ERR{alpha} Activity and MCAD Expression in Skeletal Muscle of Senescence-Accelerated Mice. J. Gerontol. A Biol. Sci. Med. Sci., August 1, 2006; 61(8): 773 - 780. [Abstract] [Full Text] [PDF]

				A. G. Smith and G. E. O. Muscat Orphan nuclear receptors: therapeutic opportunities in skeletal muscle Am J Physiol Cell Physiol, August 1, 2006; 291(2): C203 - C217. [Abstract] [Full Text] [PDF]

				A. Kishi, T. Nakamura, Y. Nishio, H. Maegawa, and A. Kashiwagi Sumoylation of Pdx1 is associated with its nuclear localization and insulin gene activation Am J Physiol Endocrinol Metab, April 1, 2003; 284(4): E830 - E840. [Abstract] [Full Text] [PDF]

				G. Schratzberger and G. Mayer Age and renal transplantation: an interim analysis Nephrol. Dial. Transplant., March 1, 2003; 18(3): 471 - 476. [Full Text] [PDF]

				B. G. Brown, M. C. Cheung, A. C. Lee, X.-Q. Zhao, and A. Chait Antioxidant Vitamins and Lipid Therapy: End of a Long Romance? Arterioscler. Thromb. Vasc. Biol., October 1, 2002; 22(10): 1535 - 1546. [Abstract] [Full Text] [PDF]

				I. Pineda Torra, Y. Jamshidi, D. M. Flavell, J.-C. Fruchart, and B. Staels Characterization of the Human PPAR{alpha} Promoter: Identification of a Functional Nuclear Receptor Response Element Mol. Endocrinol., May 1, 2002; 16(5): 1013 - 1028. [Abstract] [Full Text] [PDF]

				H. Kojima, T. Nakamura, Y. Fujita, A. Kishi, M. Fujimiya, S. Yamada, M. Kudo, Y. Nishio, H. Maegawa, M. Haneda, et al. Combined Expression of Pancreatic Duodenal Homeobox 1 and Islet Factor 1 Induces Immature Enterocytes to Produce Insulin Diabetes, May 1, 2002; 51(5): 1398 - 1408. [Abstract] [Full Text] [PDF]

				A. Khalil, J.-P. Fortin, J.-G. LeHoux, and T. Fülöp Age-related decrease of dehydroepiandrosterone concentrations in low density lipoproteins and its role in the susceptibility of low density lipoproteins to lipid peroxidation J. Lipid Res., October 1, 2000; 41(10): 1552 - 1561. [Abstract] [Full Text]